GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Editas Medicine Inc (LTS:0IFK) » Definitions » E10

Editas Medicine (LTS:0IFK) E10 : $-3.31 (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Editas Medicine E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Editas Medicine's adjusted earnings per share data for the three months ended in Dec. 2024 was $-0.550. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-3.31 for the trailing ten years ended in Dec. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-03-25), Editas Medicine's current stock price is $1.365. Editas Medicine's E10 for the quarter that ended in Dec. 2024 was $-3.31. Editas Medicine's Shiller PE Ratio of today is .


Editas Medicine E10 Historical Data

The historical data trend for Editas Medicine's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Editas Medicine E10 Chart

Editas Medicine Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -3.31

Editas Medicine Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -3.33 -3.46 -3.31

Competitive Comparison of Editas Medicine's E10

For the Biotechnology subindustry, Editas Medicine's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Editas Medicine's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Editas Medicine's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Editas Medicine's Shiller PE Ratio falls into.



Editas Medicine E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Editas Medicine's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.55/133.1571*133.1571
=-0.550

Current CPI (Dec. 2024) = 133.1571.

Editas Medicine Quarterly Data

per share eps CPI Adj_EPS
201503 -0.349 99.621 -0.466
201506 -3.087 100.684 -4.083
201509 -0.486 100.392 -0.645
201512 -0.357 99.792 -0.476
201603 -0.800 100.470 -1.060
201606 -0.540 101.688 -0.707
201609 -0.590 101.861 -0.771
201612 -1.100 101.863 -1.438
201703 -0.850 102.862 -1.100
201706 -0.650 103.349 -0.837
201709 -0.640 104.136 -0.818
201712 -0.840 104.011 -1.075
201803 -0.670 105.290 -0.847
201806 -0.820 106.317 -1.027
201809 -0.320 106.507 -0.400
201812 -0.520 105.998 -0.653
201903 -0.600 107.251 -0.745
201906 -0.690 108.070 -0.850
201909 -0.660 108.329 -0.811
201912 -0.740 108.420 -0.909
202003 -0.690 108.902 -0.844
202006 -0.430 108.767 -0.526
202009 0.120 109.815 0.146
202012 -1.000 109.897 -1.212
202103 -0.860 111.754 -1.025
202106 -0.810 114.631 -0.941
202109 -0.570 115.734 -0.656
202112 -0.610 117.630 -0.691
202203 -0.740 121.301 -0.812
202206 -0.780 125.017 -0.831
202209 -0.810 125.227 -0.861
202212 -0.880 125.222 -0.936
202303 -0.710 127.348 -0.742
202306 -0.560 128.729 -0.579
202309 -0.550 129.860 -0.564
202312 -0.230 129.419 -0.237
202403 -0.760 131.776 -0.768
202406 -0.820 132.554 -0.824
202409 -0.750 133.029 -0.751
202412 -0.550 133.157 -0.550

Add all the adjusted EPS together and divide 10 will get our e10.


Editas Medicine  (LTS:0IFK) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Editas Medicine E10 Related Terms

Thank you for viewing the detailed overview of Editas Medicine's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Editas Medicine Business Description

Traded in Other Exchanges
Address
11 Hurley Street, Cambridge, MA, USA, 02141
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.

Editas Medicine Headlines

No Headlines